Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES:
Net income (loss)	$ (54,045)	$ 119,836
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation expense	27,011	32,324
Depreciation and amortization expense, including amortization of deferred financing costs	156,841	160,797
Deferred rent	(20,594)	(14,764)
Loss from unconsolidated real estate ventures, net	1,320	12,829
Amortization of market lease intangibles, net	(767)	(874)
Amortization of lease incentives	1,812	6,175
Loss on the extinguishment of debt	450	3,073
Impairment loss	59,307
Gain on the sale of real estate, net	(41,606)	(158,631)
(Income) loss on operating lease and other receivables	(67)	1,392
Income from investments, net	(1,163)	(14,733)
Return on capital from unconsolidated real estate ventures	12,633	8,483
Other non-cash items	8,586	(7,352)
Changes in operating assets and liabilities:
Tenant and other receivables	12,223	(5,044)
Other assets, net	(22,305)	(20,552)
Accounts payable and accrued expenses	(18,129)	(3,648)
Other liabilities, net	(6,614)	11,055
Net cash provided by operating activities	114,893	130,366
INVESTING ACTIVITIES:
Development costs, construction in progress and real estate additions	(241,336)	(218,835)
Acquisition of real estate	(19,551)	(15,232)
Deposits for real estate and other acquisitions		(1,750)
Proceeds from the sale of real estate	162,092	923,108
Proceeds from the sale of investments		19,030
Proceeds from derivative financial instruments	465
Payments on derivative financial instruments	(9,830)
Distributions of capital from unconsolidated real estate ventures and other investments	9,264	54,759
Investments in unconsolidated real estate ventures and other investments	(24,344)	(86,678)
Net cash (used in) provided by investing activities	(123,240)	674,402
FINANCING ACTIVITIES:
Borrowings under mortgage loans	287,582	134,263
Borrowings under revolving credit facility	247,000	100,000
Borrowings under term loans	170,000	150,000
Repayments of mortgage loans	(280,135)	(268,627)
Repayments of revolving credit facility	(155,000)	(300,000)
Proceeds from derivative financial instruments	9,600
Payments on derivative financial instruments	(465)
Debt issuance and modification costs	(17,579)	(5,135)
Redemption of partner's noncontrolling interest	(647)
Proceeds from common shares issued pursuant to ESPP	665	800
Common shares repurchased	(273,851)	(361,042)
Dividends paid to common shareholders	(72,483)	(82,072)
Distributions to redeemable noncontrolling interests	(11,619)	(12,398)
Distributions to noncontrolling interests	(15)	(166)
Contributions from noncontrolling interests		9,383
Net cash used in financing activities	(96,947)	(634,994)
Net (decrease) increase in cash and cash equivalents, and restricted cash	(105,294)	169,774
Cash and cash equivalents, and restricted cash, beginning of period	274,073	302,095
Cash and cash equivalents, and restricted cash, end of period	168,779	471,869
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION:
Cash paid for interest (net of capitalized interest of $11,013 and $6,816 in 2023 and 2022)	65,416	52,620
Accrued capital expenditures included in accounts payable and accrued expenses	80,946	74,735
Write-off of fully depreciated assets	3,489	10,642
Conversion of OP Units to common shares	33,110	12,667
Recognition of operating lease right-of-use asset	61,443
Recognition of liabilities related to operating lease right-of-use asset	61,443
Cash paid for amounts included in the measurement of lease liabilities for operating leases	$ 3,567	$ 1,638